Therapeutic Approach to Diastolic Dysfunction in Chronic Liver Disease Patients and Its Impact on Morbidity and Mortality
Status:
Completed
Trial end date:
2016-08-31
Target enrollment:
Participant gender:
Summary
Cirrhotic cardiomyopathy is defined as a chronic cardiac dysfunction in patients with
cirrhosis. It is suspected that this specific cardiac dysfunction contributes to the onset of
complications in liver disease. The purpose of this prospective, randomized controlled trial
is to determine whether carvedilol can revert cardiac dysfunction i.e. left ventricular
diastolic dysfunction secondary to cirrhosis, and prevent complications (renal dysfunction,
worsening cardiac function, and mortality).